Mirae Asset Global Investments’s Pacific Biosciences PACB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4K Buy
11,592
+2,355
+25% +$2.92K ﹤0.01% 1442
2025
Q1
$10.5K Buy
9,237
+111
+1% +$127 ﹤0.01% 1466
2024
Q4
$17K Sell
9,126
-731
-7% -$1.36K ﹤0.01% 1443
2024
Q3
$17.3K Buy
9,857
+1,726
+21% +$3.02K ﹤0.01% 1453
2024
Q2
$11.1K Sell
8,131
-1,327,731
-99% -$1.81M ﹤0.01% 1454
2024
Q1
$12.2M Buy
1,335,862
+408,874
+44% +$3.72M 0.03% 555
2023
Q4
$9.09M Sell
926,988
-507,572
-35% -$4.98M 0.02% 686
2023
Q3
$12M Buy
1,434,560
+41,970
+3% +$350K 0.03% 554
2023
Q2
$18.5M Buy
1,392,590
+30,767
+2% +$409K 0.04% 442
2023
Q1
$15.8M Buy
1,361,823
+400
+0% +$4.63K 0.04% 463
2022
Q4
$11.1M Buy
1,361,423
+205,809
+18% +$1.68M 0.03% 563
2022
Q3
$6.71M Buy
1,155,614
+176,087
+18% +$1.02M 0.02% 707
2022
Q2
$4.33M Buy
979,527
+602,257
+160% +$2.66M 0.01% 886
2022
Q1
$3.43M Sell
377,270
-68,930
-15% -$627K 0.01% 993
2021
Q4
$9.13M Buy
446,200
+95,609
+27% +$1.96M 0.02% 707
2021
Q3
$8.96M Buy
350,591
+69,263
+25% +$1.77M 0.02% 685
2021
Q2
$9.84M Sell
281,328
-85,483
-23% -$2.99M 0.03% 639
2021
Q1
$12.2M Buy
366,811
+165,541
+82% +$5.51M 0.04% 481
2020
Q4
$5.22M Buy
201,270
+69,947
+53% +$1.81M 0.02% 645
2020
Q3
$1.3M Buy
131,323
+41,588
+46% +$410K 0.01% 889
2020
Q2
$309K Buy
89,735
+31,933
+55% +$110K ﹤0.01% 1291
2020
Q1
$176K Buy
57,802
+6,292
+12% +$19.2K ﹤0.01% 1339
2019
Q4
$265K Buy
51,510
+5,416
+12% +$27.9K ﹤0.01% 1373
2019
Q3
$238K Buy
46,094
+32,713
+244% +$169K ﹤0.01% 1353
2019
Q2
$81K Buy
+13,381
New +$81K ﹤0.01% 1383